EUVIMEDEUVIMED entdecken
Open Access

Comprehensive bioinformatics analytics and in vivo validation reveal SLC31A1 as an emerging diagnostic biomarker for acute myocardial infarction

Shujing Zhou, Longbin Wang, Xufeng Huang, Ting Wang, Yidan Tang, Ying Liu, Ming Xu

Aging · 2024

DOI: 10.18632/aging.205199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Shujing Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Veterinary Medicine, Huazhong Agricultural University, Wuhan, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Computational Biology, Biomarkers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Globally, Acute Myocardial Infarction (AMI) is a common cause of heart failure (HF), which has been a leading cause of mortality resulting from non-communicable diseases. On the other hand, increasing evidence suggests that the role of energy production within the mitochondria strongly links to the development and progression of heart diseases, while Cuproptosis, a newly identified cell death mechanism, has not yet been comprehensively analyzed from the aspect of cardiovascular medicine. MATERIALS AND METHODS: 8 transcriptome profiles curated from the GEO database were integrated, from which a diagnostic model based on the Stacking algorithm was established. The efficacy of the model was evaluated in a multifaced manner (i.e., by Precision-Recall curve, Receiver Operative Characteristic curve, etc.). We also sequenced our animal models at the bulk RNA level and conducted qPCR and immunohistochemical staining, with which we further validated the expression of the key contributor gene to the model. Finally, we explored the immune implications of the key contributor gene. RESULTS: A merged machine learning model containing 4 Cuproptosis-related genes (i.e., PDHB, CDKN2A, GLS, and SLC31A1) for robust AMI diagnosis was developed, in which SLC31A1 served as the key contributor. Through in vivo modeling, we validated the aberrant overexpression of SLC31A1 in AMI. Besides, further transcriptome analysis revealed that its high expression was correlated with significant potential immunological implications in the infiltration of many immune cell types, especially monocyte. CONCLUSIONS: We constructed an AMI diagnostic model based on Cuproptosis-related genes and validated the key contributor gene in animal modeling. We also analyzed the effects on the immune system for its overexpression in AMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionComputational BiologyBiomarkersAnimalsHumansCation Transport ProteinsTranscriptomeDisease Models, AnimalMachine LearningMiceCyclin-Dependent Kinase Inhibitor p16MaleGene Expression Profiling

Stichwörter der Autor:innen

acute myocardial infarctionbioinformaticscuproptosisdiagnostic biomarkersmachine learning

Substanzen

BiomarkersCation Transport ProteinsCyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • Department of Clinical Veterinary Medicine, Huazhong Agricultural University, Wuhan, China.
  • Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Department of Cardiology, Sixth Medical Center, PLA General Hospital, Beijing, China.

Zitieren

APA

Zhou, S., Wang, L., Huang, X., Wang, T., Tang, Y., Liu, Y., & Xu, M. (2024). Comprehensive bioinformatics analytics and in vivo validation reveal SLC31A1 as an emerging diagnostic biomarker for acute myocardial infarction. Aging. https://doi.org/10.18632/aging.205199

Vancouver

Zhou S, Wang L, Huang X, Wang T, Tang Y, Liu Y, et al. Comprehensive bioinformatics analytics and in vivo validation reveal SLC31A1 as an emerging diagnostic biomarker for acute myocardial infarction. Aging. 2024. doi:10.18632/aging.205199

BibTeX
@article{Zhou2024,
  author = {Zhou, Shujing and Wang, Longbin and Huang, Xufeng and Wang, Ting and Tang, Yidan and Liu, Ying and Xu, Ming},
  title = {Comprehensive bioinformatics analytics and in vivo validation reveal SLC31A1 as an emerging diagnostic biomarker for acute myocardial infarction},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205199}
}
Kostenlos starten →